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g5R proteinThe African Swine Fever Virus (ASFV) encodes a single Nudix enzyme in its genome, termed the g5R protein
(g5Rp). Nudix phosphohydrolases cleave a variety of substrates, such as nucleotides and diphosphoinositol
polyphosphates. Previously, ASFV g5Rp was shown to hydrolyze diphosphoinositol polyphosphates and GTP,
but was unable to cleave methylated mRNA cap analogues. In vaccinia virus (VACV), a distant relative of
ASFV, the D9 and D10 Nudix enzymes were shown to cleave the mRNA cap, but only when the cap was
attached to an RNA body. Here, we show that recombinant ASFV g5Rp hydrolyzes the mRNA cap when
tethered to an RNA moiety, liberating m7GDP as a product. Mutations in the Nudix motif abolished mRNA
decapping activity, conﬁrming that g5Rp was responsible for cap cleavage. The decapping activity of g5Rp
was potently inhibited by excess uncapped RNA but not by methylated cap analogues, suggesting that
substrate recognition occurs by RNA binding.
© 2009 Elsevier Inc. All rights reserved.Introduction
The Nudix hydrolase motif is a signature sequence characteristic of
a diverse group of phosphohydrolases found in viruses, prokaryotes,
and eukaryotes (reviewed inMcLennan, 2006). Nudix enzymes cleave
a broad group of substrates that are generally comprised of a nu-
cleoside diphosphate linked to another moiety, X (Koonin, 1993;
Bessman et al., 1996). Interestingly, the Nudix enzymes found in
viruses are restricted almost exclusively to the ﬁve viral families that
belong to the monophyletic lineage of large nucleocytoplasmic DNA
viruses, comprised of poxviruses, asfarviruses, iridoviruses, phycod-
naviruses andmimiviruses, suggesting possible overlapping functions
for these proteins (Iyer et al., 2001; Iyer et al., 2006).
The D9 and D10 proteins of vaccinia virus (VACV), the prototypic
poxvirus, are Nudix hydrolases that share 25% sequence identity to
each other (Shors et al., 1999). D9 and D10 are expressed at different
times during virus infection; D9 is expressed early whereas D10 is
expressed during the late phase of viral infection (Lee-Chen and Niles,
1988; Parrish andMoss, 2006). Previous genetic studies demonstrated
that over-expression of the D9R (VACV-WR_114) or the D10R (VACV-
WR_115) gene resulted in enhanced turnover of mRNA molecules
containing a 5′m7GpppNm cap, a stabilizing component of both VACV
and cellular transcripts (Shors et al., 1999). Moreover, deletion of the
D10R gene from the VACV genome resulted in the persistence of
cellular and viral transcripts and a delay in the shutoff of host protein
synthesis (Parrish and Moss, 2006). These two genetic observationsl rights reserved.led to the hypothesis that D9 and D10 cleave the mRNA cap, thereby
accelerating viral and cellular mRNA turnover and promoting the
sequential cascade of viral gene expression and the shutoff of host
protein synthesis. In support of this hypothesis, Dcp2, a Nudix enzyme
conserved from yeasts to mammals, has been shown to be an mRNA
decapping enzyme (Wang et al., 2002; van Dijk et al., 2002; Steiger et
al., 2003; Cohen et al., 2005; Xu et al., 2006).
More recent biochemical studies conﬁrmed that both VACV D9
and D10 contain intrinsic mRNA decapping activity, releasing m7GDP
as a reaction product (Parrish et al., 2007; Parrish and Moss, 2007).
Similar to eukaryotic Dcp2, D9 and D10 were unable to efﬁciently
cleave a free methylated cap analogue (m7GpppNm); robust decap-
ping activity was only observed when the methylated cap structure
was tethered to an RNA moiety (Wang et al., 2002; van Dijk et al.,
2002; Piccirillo et al., 2003; Steiger et al., 2003; Cohen et al., 2005;
Parrish et al., 2007; Parrish and Moss, 2007). In accord with this
observation, uncapped RNA inhibited D9 and D10 decapping activity,
suggesting RNA binding is required for these proteins to locate and
cleave the cap structure (Parrish et al., 2007; Parrish and Moss, 2007).
In addition, free methylated cap derivatives inhibited cap cleavage by
D9 and D10, indicating that these proteins may also interact with
the cap structure during substrate recognition (Parrish et al., 2007;
Parrish and Moss, 2007).
African Swine Fever Virus (ASFV), the lone representative of the
Asfarviridae virus family, encodes a single Nudix enzyme in its
genome, denoted as the g5R protein (g5Rp) (NCBI ID: NP_042795)
(Cartwright et al., 2002). Intriguingly, ASFV g5Rp shares greater
sequence similarity to the Schizosaccharomyces pombe Dcp2 mRNA
decapping enzyme than either VACV D9 or D10 (McLennan, 2007).
Previous biochemical studies demonstrated that g5Rp hydrolyzes a
Fig. 1. Recombinant ASFV g5Rp catalyzes RNA cap cleavage. (A) ASFV g5Rp was
expressed as an MBP-g5R fusion protein appended with a C-terminal His10 tag in
Escherichia coli and then puriﬁed over amylose and nickel-nitrilotriacetic acid
columns. Puriﬁed recombinant g5Rp was resolved by SDS/PAGE and detected by
staining with Coomassie blue. Protein mass standards (in kDa) are labeled on the left
whereas the ∼75-kDa recombinant MBP-g5R-HIS band is indicated on the right. (B)
75 ng of recombinant ASFV g5Rp was incubated with 0.02 pmol of 32P-cap-labeled
actin RNA in decapping buffer for 30 min at 37 °C. A portion of this reaction was
treated with 2 U of nucleoside diphosphate kinase (NDPK) and 1 mM ATP for an
additional 30 min at 37 °C. NDPK adds a phosphate group exclusively to nucleoside
diphosphates, resulting in the production of nucleoside triphosphates. Reaction
products were resolved by PEI-cellulose TLC and detected by autoradiography.
Unlabeled nucleotide standards were visualized by UV shadowing and are designated
on the right.
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polyphosphates but also hydrolyzing nucleotide substrates such as
GTP (Cartwright et al., 2002). Despite its broad substrate range, g5Rp
was unable to efﬁciently cleave free methylated cap analogues, which
led to the conclusion that g5Rp was not an mRNA decapping enzyme
(Cartwright et al., 2002). However, in light of the recent observations
that cap attachment to an mRNA body is required for Nudix-mediated
mRNA decapping, the role of g5Rp in this process needs to be
reevaluated (Wang et al., 2002; van Dijk et al., 2002; Piccirillo et al.,
2003; Steiger et al., 2003; Cohen et al., 2005; Parrish et al., 2007;
Parrish and Moss, 2007).
To examine if ASFV g5Rp possesses mRNA decapping activity, a
g5Rp fusion protein was expressed in bacteria and subsequently
puriﬁed by afﬁnity chromatography. In contrast with the limited
activity of g5Rp on free methylated cap analogues, g5Rp was able to
robustly cleave a cap structure attached to an mRNA moiety in a
manner dependent on the Nudix motif, releasing m7GDP as a product.
g5Rp-decapping activity was inhibited by uncapped RNA but not
methylated cap analogue derivatives, suggesting that g5Rp recognizes
the RNA moiety to ﬁnd target substrates.
Results
Recombinant ASFV g5Rp decaps mRNA
Although it was previously shown that ASFV g5Rp cannot cleave
a free methylated cap structure, recent studies demonstrated that
mRNA decapping mediated by Nudix enzymes is dependent on the
methylated cap structure being tethered to an mRNA body (Wang
et al., 2002; van Dijk et al., 2002; Piccirillo et al., 2003; Steiger et al.,
2003; Cohen et al., 2005; Parrish et al., 2007; Parrish and Moss,
2007). To determine if the ASFV g5Rp can cleave a cap structure on
an intact mRNA, a maltose binding protein (MBP)–g5R fusion pro-
tein containing a C-terminal His10 tag (MBP-g5R-HIS) was ex-
pressed in Escherichia coli and puriﬁed by afﬁnity chromatography
through amylose and nickel-nitrilotriacetic acid columns. Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS/PAGE)
analysis of the puriﬁed protein fractions revealed a single ∼75-
kDa band corresponding to the predicted mass of MBP-g5R-HIS
(Fig. 1A).
Next, the recombinant g5Rp was incubated with a 309-nt 32P-
cap-labeled RNA substrate and the products of the reaction were
resolved by polyethyleneimine (PEI)-cellulose thin layer chroma-
tography (TLC) and detected by autoradiography. Unlabeled nucle-
otide standards were visualized by UV shadowing. In the absence of
recombinant g5Rp, the 32P-cap-labeled RNA substrate remained at
the origin of the plate (Fig. 1B). However, inclusion of recombinant
g5Rp in the decapping reaction resulted in the release of a product
that co-migrated with an unlabeled m7GDP standard (Fig. 1B). To
conﬁrm the identity of the released m7GDP product, a portion of the
decapping reaction was incubated with nucleoside diphosphate
kinase (NDPK), an enzyme that speciﬁcally adds a phosphate group
to nucleoside diphosphate substrates, thereby producing nucleo-
side triphosphate products. Following treatment with NDPK and
resolution by PEI-cellulose TLC, the m7GDP product shifted to co-
migrate with the unlabeled m7GTP standard, verifying that the pro-
duct originally released by g5Rp was m7GDP (Fig. 1B). The amount
of product liberated by g5Rp cap cleavage increased with increas-
ing enzyme concentration and incubation time (Figs. 2A and B,
respectively).
The Nudix motif of ASFV g5Rp is required for mRNA decapping
The Nudix hydrolase motif consists of the highly conserved
amino acid sequence GX5EX5[UA]XREX2EEXGU where U represents
an aliphatic, hydrophobic residue and X represents any amino acid(Koonin, 1993; Bessman et al., 1996). For several Nudix hydro-
lases, the glutamic acid residues in the EX2EE sequence have been
shown to be essential for catalytic activity, coordinating divalent
cation binding and nucleophilic attack of the phosphate bond
(reviewed in Mildvan et al., 2005). To demonstrate that recombi-
nant g5Rp was solely responsible for cap cleavage in a manner
dependent on the Nudix motif, mutations were introduced in the
critical EX2EE residues of this sequence. Speciﬁcally, one g5R
mutant protein was synthesized in which the glutamic acid at
residue 147 was converted into a glutamine (E147Q). A second
g5R mutant protein was created in which the two glutamic acid
residues at positions 150 and 151 were changed to glutamine
residues (E150Q/E151Q). These two mutant proteins were
expressed and puriﬁed concomitantly with wild-type recombinant
g5Rp and resolved by SDS/PAGE (Fig. 3A). As expected, incubation
of the 32P-cap-labeled RNA substrate with wild-type g5Rp resulted
in cap cleavage, as observed by m7GDP release (Fig. 3B). When
equivalent amounts of the two mutant versions of the g5Rp were
Fig. 2. Effects of enzyme concentration and time on ASFV g5Rp cap cleavage activity.
(A) Increasing amounts of recombinant g5Rp were added to 0.02 pmol of 32P-cap-
labeled actin RNA in decapping buffer for 30 min at 37 °C. Following resolution of the
products by PEI-cellulose TLC, the percentage of m7GDP product released was calcu-
lated using a PhosphorImager. (B) 50 ng of recombinant g5Rp was assessed for mRNA
decapping activity as in panel A, except that incubation times varied as indicated on
the graph.
Fig. 3. The Nudix motif is required for ASFV g5rp mRNA decapping activity. (A) Two
mutated versions of g5Rp, E147Q and E150Q/E151Q, were created through site-
directed mutagenesis. The E147Qmutant contains a point mutation at position 147 that
changes a glutamic acid residue to a glutamine residue. Likewise, E150Q/E151Q
contains two point mutations in which the glutamic acid residues at positions 150 and
151 have both been transformed to glutamine residues. The E147Q and E150Q/E151Q
mutant proteins were expressed in Escherichia coli and puriﬁed concurrently with wild-
type recombinant g5Rp as described in Fig. 1A. The puriﬁed proteins were
electrophoretically separated by SDS/PAGE and visualized by Coomassie blue staining.
Masses of protein markers (in kDa) are indicated on the left. (B) Equal quantities
(100 ng) of recombinant g5Rp and the two mutated proteins (E147Q and E150Q/
E151Q) were included in separate decapping reactions and assayed for cap hydrolysis
as described in Fig. 1B.
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verifying that g5Rp was the protein responsible for mRNA decapping
and that this activity was dependent on the Nudix hydrolase motif
(Fig. 3B).
The ASFV g5Rp recognizes the RNA body
The ﬁnding that g5Rp requires an RNA moiety to mediate mRNA
decapping suggests that this protein binds mRNA to locate its
substrate. To investigate if g5Rp interacts withmRNA during substrate
recognition, increasing amounts of uncapped RNA substrate were
included in the decapping reaction and the effect on g5Rp decapping
activity was calculated. Inclusion of even amodest 1-foldmolar excess
of uncapped RNA reduced g5R decapping activity by greater than
∼81%, compared to the ∼17% reduction of decapping activity
observed for VACV D10 (Fig. 4A). In fact, the signiﬁcant inhibition of
g5Rp decapping activity by such minute amounts of uncapped RNA
hindered efforts to determine kinetic constants for the g5R enzyme.
Each cap-labeled RNA substrate preparation contains a proportion of
uncapped RNA. Kinetic parameters are calculated by increasing the
amount of substrate while maintaining a constant enzyme concen-
tration; hence as the amount of substrate was increased, the
subsequent rise in uncapped RNA competitor abolished g5Rp-
decapping activity.
To directly determine if ASFV g5Rp is capable of binding RNA, an
electrophoretic gel mobility assay was performed in which non-
denaturing PAGE was employed to resolve a uniformly 32P-labeled
309-nt uncapped RNA. As a positive control, the RNA binding
protein mDAZL was added to the labeled RNA, resulting in a shift in
the migration of the RNA through the gel (Fig. 4B) (Jiao et al.,
2002). Conversely, MBP alone, which should not bind RNA, did not
shift the mobility of the RNA (Fig. 4B). Upon addition of the re-
combinant ASFV g5Rp, a shift in mobility was observed for a por-
tion of the RNA, suggesting that g5Rp bound to the RNA and
reduced its mobility through the gel matrix (Fig. 4B). The incom-plete RNA shift exerted by g5R may reﬂect a transient interaction
between g5R and RNA in the absence of a cap structure; alter-
natively, the RNA–protein complex may have partially dissociated
upon electrophoresis.
The mRNA decapping activity of ASFV g5rp is not inhibited by
methylated nucleotides
The mRNA decapping activity of the VACV D9 and D10 proteins
was inhibited by m7GpppG, m7GTP, and m7GDP, with D10 mRNA
decapping activity being more hindered by these methylated cap
structures than D9 (Parrish et al., 2007; Parrish and Moss, 2007). To
determine if ASFV g5rp activity was also inhibited by addition of
methylated nucleotides, increasing amounts of m7GpppG or m7GTP,
or the unmethylated versions of these nucleotides, were added to the
decapping reactions and the amount of product released was
calculated. The addition of either m7GpppG or m7GTP had no effect
on g5R cap cleavage, suggesting that this protein may not recognize
the cap structure to locate its substrate (Figs. 5A and B). Interestingly,
g5R decapping activity was not inhibited by GTP or GpppG, despite
the observation that g5R was capable of cleaving GTP and GpppG in
vitro (Cartwright et al., 2002). The ability of the recombinant g5Rp to
Fig. 4. ASFV g5Rp recognizes the RNAmoiety. (A) Uncapped, unlabeled 309-nt actin RNA
was added in increasing quantities to decapping reactions containing either 80 ng of
recombinant ASFV g5Rp or VACV D10. The reaction products were separated by PEI-
cellulose TLC and quantiﬁed by PhosphorImager analysis. (B) Recombinant ASFVg5Rp and
uniformly 32P-labeled uncapped actin RNA were incubated in electrophoretic mobility
shift assay buffer. After 15 min on ice, the reactions were separated on a 6% native
polyacrylamide gel and visualized using a PhosphorImager. mDAZL, a characterized RNA
binding protein, was used as a positive control for RNA binding (Jiao et al., 2002). MBP,
which should not bind RNA, was utilized as a negative control for the assay.
Fig. 5. ASFV g5Rp decapping activity is not affected by cap analogue or methylated
nucleotides. (A) 80 ng of recombinant ASFV g5Rp or VACV D10 and 0.02 pmol of 32P-
cap-labeled actin RNA were incubated with increasing amounts of m7GpppG or GpppG
and the products of the reaction were resolved by PEI-cellulose TLC. The percentage of
m7GDP releasedwas quantiﬁed using PhosphorImager analysis. (B) Increasing amounts
of m7GTP or GTP were added to the decapping reaction and quantiﬁed as in panel A.
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shown).
Discussion
The nearly exclusive restriction of viral Nudix enzymes to the
ancestral lineage of the large nucleocytoplasmic DNA viruses suggests
that these proteins may have analogous functions. In VACV, the D9
and D10 Nudix enzymes were shown to hydrolyze the mRNA cap
structure, thereby accelerating mRNA turnover and allowing the virus
to manipulate host and viral gene expression (Parrish et al., 2007;
Parrish and Moss, 2007). ASFV, another member of the large
nucleocytoplasmic DNA virus lineage, encodes a single Nudix enzyme
in its genome, g5Rp, which shares greater sequence similarity to VACV
D10 than D9. Previous studies suggested that ASFV g5Rp was not an
mRNA decapping enzyme, given that the enzyme did not cleave free
cap analogues in vitro (Cartwright et al., 2002). However, in the
present study, recombinant ASFV g5Rp was shown to possess
decapping activity, efﬁciently hydrolyzing the cap structure only
when attached to an mRNA molecule, mimicking VACV D9 and D10
and eukaryotic Dcp2 substrate requirements (Wang et al., 2002; van
Dijk et al., 2002; Piccirillo et al., 2003; Steiger et al., 2003; Cohen et al.,
2005; Parrish et al., 2007; Parrish andMoss, 2007). Indeed, ASFV g5Rp
shares greater sequence similarity to eukaryotic Dcp2 than either
VACV D9 or D10 (McLennan, 2007), further implicating g5Rp as anmRNA decapping enzyme. The product released by g5Rp cleavage of
the mRNA cap was conﬁrmed to be m7GDP, distinguishing g5Rp
activity from DcpS, a eukaryotic enzyme that cleaves free mRNA caps
to release m7GMP as a reaction product (Wang and Kiledjian, 2001).
Importantly, g5Rp-decapping activity was abolished by mutations in
critical Nudix motif residues, conﬁrming that catalytic activity was
dependent on the Nudix motif and that g5Rp was the protein directly
responsible for the mRNA decapping activity.
Like VACV D9 and D10, as well as eukaryotic Dcp2, ASFV g5Rp
mRNA decapping activity was strongly inhibited by uncapped mRNA,
further supporting the requirement of the mRNAmoiety for substrate
recognition (Piccirillo et al., 2003; Cohen et al., 2005; Parrish et al.,
2007; Parrish andMoss, 2007; Gunawardana et al., 2008). The effect of
uncapped mRNA was much more striking for ASFV g5Rp than VACV
D9 or D10 (g5RpND9ND10), suggesting g5Rp may have a stronger
afﬁnity for RNA than the VACV enzymes (Parrish et al., 2007; Parrish
and Moss, 2007). Moreover, g5Rp was shown to directly bind mRNA
through an electrophoretic gel shift assay. A complete shift of the RNA
by g5Rp was not observed, suggesting that the cap structure may be
required to stabilize the g5Rp–RNA interaction. Alternatively, g5Rp
may only have strong afﬁnity for target RNA molecules that possess a
particular secondary structure. For example, human Dcp2 has been
shown to preferentially bind mRNA targets containing a speciﬁc 5′
stem loop structure (Li et al., 2008; and Li et al., 2009). Furthermore,
eukaryotic Dcp2 contains two additional domains that modulate
enzyme function: Box A, a region thought to be involved in protein–
protein interactions and cleavage speciﬁcity, and Box B, which is
proposed to bind RNA (Wang et al., 2002; Piccirillo et al., 2003). Only
weak sequence similarity can be detected between these regions of
Dcp2 and the VACV and ASFV enzymes; future structure/function
analyses need to be performed to deﬁne the RNA binding domains in
the viral decapping enzymes. In contrast to RNA, free methylated cap
derivatives had no effect on ASFV g5Rp decapping, whereas they
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D9 decapping (D10ND9Ng5Rp) (Parrish et al., 2007; Parrish and
Moss, 2007). In this respect, ASFV g5Rp more closely resembles
eukaryotic Dcp2, which is not affected by the addition of methylated
cap derivatives unattached to RNA (van Dijk et al., 2002; Piccirillo et
al., 2003; Cohen et al., 2005).
Similar to VACV, ASFV mRNA transcripts are capped by a virally
encoded capping enzyme and expressed in a programmed temporal
cascade (Salas et al., 1981; Salas et al., 1986; Carvalho and Rodrigues-
Pousada, 1986; Santaren and Vinuela, 1986). Moreover, ASFV infec-
tion induces a shutoff of host protein synthesis, potentially allowing
the virus preferential access to translation machinery and macromo-
lecular building blocks, while also hindering synthesis of immuno-
modulatory proteins (Tabares et al., 1980; Rodriguez et al., 2001).
Hence, g5Rp mediated mRNA decapping may provide the virus with a
mechanism to regulate the transitions between viral gene expression
and promote the shutoff of host protein synthesis. In addition to the
mRNA cap, ASFV g5Rp has also been shown to efﬁciently hydrolyze
diphosphoinositol polyphosphates and GTP in vitro, raising the
possibility that g5Rp may have multiple in vivo functions, not unusual
for viral enzymes (Cartwright et al., 2002). Future studies examining
the effects of deletion or over-expression of the g5R gene should help
clarify the in vivo function(s) of ASFV g5Rp.
Materials and methods
Plasmid construction
An Escherichia coli codon optimized version of the ASFV g5R gene
appended with a C-terminal 10× histidine tag was synthesized by
GENEART (Regensburg, Germany) and used as template for ampli-
ﬁcation by the polymerase chain reaction (PCR) using the oligo-
nucleotide primers 5′-ATG GAT ACC GCC ATG CAG CTG AAA ACC AGC
and 5′-GCG CAA GCT TTT AAT GGT GAT GGT GAT GAT GGT GGT GAT G.
The gel puriﬁed PCR product was cloned into the pMal-c2x protein
expression vector (New England Biolabs, Ipswich, MA) immediately
downstream of the malE gene, creating the pMAL-c2x-malE-g5R-his
plasmid that encodes the MBP-g5R-10× histidine (MBP-g5R-HIS)
recombinant protein. Mutated versions of MBP-g5R-HIS were gener-
ated through use of the Quikchange site-directed mutagenesis kit
(Stratagene, La Jolla, CA).
Expression and puriﬁcation of recombinant ASFV g5R protein
Escherichia coli strain BL21 (EMD Biosciences, San Diego, CA) was
transformed with wild-type or mutated versions of pMAL-c2x-malE-
g5R-his and propagated in LB broth containing 50 μg/ml carbenicillin
and 0.2% (w/v) glucose. Recombinant protein synthesis was induced
with 0.3 mM isopropyl β-D-1 thiogalactopyranoside at 30 °C. After 4 h,
the cells were lysed in B-per detergent (Pierce, Rockford, IL) and the
recombinant protein was puriﬁed through an amylose column (New
England Biolabs) followed by a nickel-nitrilotriacetic acid column
(Qiagen, Valencia, CA). The puriﬁed protein was then dialyzed into
10 mM Tris–HCl pH 7.5, 100 mM NaCl, 10% glycerol, 1 mM DTT, and
2 mM Mg acetate (Piccirillo et al., 2003). Recombinant MBP-D10 was
synthesized and puriﬁed as described by Parrish et al. (2007).
RNA substrate synthesis
The pTRI-β-actin-human template (Ambion, Austin, TX) was in
vitro transcribed using the MEGAshortscript kit (Ambion) and the
resulting 309-nt actin RNA was cap-labeled using recombinant VACV
guanylyltransferase/guanine-7-methyltransferase (Martin and Moss,
1975) acquired from Epicentre Biotechnologies (Madison, WI) in the
presence of 0.132 μM [α32P] GTP, capping buffer (50 mM Tris–HCl pH
8.0, 6 mM KCl, 1.25 mM DTT, 1.25 MgCl2) and 0.1 mM S-adenosylmethionine. Unincorporated nucleotides were removed
from the cap-labeled RNA through use of ProbeQuant G-50 gel ﬁltra-
tion columns (GE Healthcare, Piscataway, NJ).
RNA decapping assays
Reaction mixtures (15 μl) containing decapping buffer (100 mM K
acetate, 10 mM Tris–HCl pH 7.5, 2 mM MgCl2, 0.5 mM MnCl2, and
2 mM DTT), 0.02 pmol of cap-labeled RNA, and approximately
1.05 pmol (80 ng) puriﬁed recombinant MBP-g5R-HIS protein (unless
speciﬁed otherwise) were incubated for 30 min at 37 °C (Piccirillo et
al., 2003). The products of the reaction (2 μl) were spotted on a
polyethyleneimine-cellulose thin layer chromatography plate (All-
tech Associates, Inc., Columbia, MD) and developed in 0.75 M LiCl. The
radioactive signals were visualized by autoradiography or Phosphor-
Imager analysis (Molecular Dynamics, Sunnyvale, CA) and unlabeled
TLC standards were detected by UV shadowing.
Electrophoretic mobility shift assay
Increasing amounts of recombinant ASFV g5Rp (0.28 μg, 0.56 μg,
and 1.1 μg) were incubated with uniformly 32P-labeled uncapped
actin RNA in electrophoretic mobility shift assay buffer (10 mM Tris–
HCl, pH 7.5, 50 mM KCl, 1.5 mM MgCl2) on ice for 15 min. 1.1 μg of
mDAZL, an RNA binding protein, was utilized as a positive control for
RNA binding (Jiao et al., 2002). As a negative control, 2 μg of
recombinant MBP, which should not possess mRNA binding activity,
was incubated with the 32P-labeled RNA substrate. Protein–RNA
complexes were resolved on a 6% native polyacrylamide gel that was
subsequently visualized by PhosphorImager analysis.
Acknowledgments
We thank Wolfgang Resch, George Katsafanas, and Teri Shors for
helpful discussions. This research was supported by the Intramural
Research Program of the National Institute of Allergy and Infectious
Diseases/National Institutes of Health and a McDaniel College Faculty
Development Grant.
References
Bessman, M.J., Frick, D.N., O'Handley, S.F., 1996. The MutT proteins or “Nudix”
hydrolases, a family of versatile, widely distributed, “housecleaning” enzymes.
J. Biol. Chem. 271, 25059–25062.
Cartwright, J.L., Safrany, S.T., Dixon, L.K., Darzynkiewicz, E., Stepinski, J., Burke, R.,
McLennan, A.G., 2002. The g5R (D250) gene of African swine fever virus encodes
a Nudix hydrolase that preferentially degrades diphosphoinositol polyphos-
phates. J. Virol. 76, 1415–1421.
Carvalho, Z.G., Rodrigues-Pousada, C., 1986. African swine fever virus gene expression
in infected Vero cells. J. Gen. Virol. 67 (Pt 7), 1343–1350.
Cohen, L.S., Mikhli, C., Jiao, X., Kiledjian, M., Kunkel, G., Davis, R.E., 2005. Dcp2 Decaps
m2,2,7GpppN-capped RNAs, and its activity is sequence and context dependent.
Mol. Cell Biol. 25, 8779–8791.
Gunawardana, D., Cheng, H.C., Gayler, K.R., 2008. Identiﬁcation of functional domains in
Arabidopsis thaliana mRNA decapping enzyme (AtDcp2). Nucleic Acids Res. 36,
203–216.
Iyer, L.M., Aravind, L., Koonin, E.V., 2001. Common origin of four diverse families of large
eukaryotic DNA viruses. J. Virol. 75, 11720–11734.
Iyer, L.M., Balaji, S., Koonin, E.V., Aravind, L., 2006. Evolutionary genomics of nucleo-
cytoplasmic large DNA viruses. Virus Res. 117, 156–184.
Jiao, X., Triﬁllis, P., Kiledjian, M., 2002. Identiﬁcation of target messenger RNA substrates
for the murine deleted in azoospermia-like RNA-binding protein. Biol. Reprod. 66,
475–485.
Koonin, E.V., 1993. A highly conserved sequence motif deﬁning the family of MutT-
related proteins from eubacteria, eukaryotes and viruses. Nucleic Acids Res. 21,
4847.
Lee-Chen, G.J., Niles, E.G., 1988. Transcription and translation mapping of the 13 genes
in the vaccinia virus HindIII D fragment. Virology 163, 52–63.
Li, Y., Song, M.G., Kiledjian, M., 2008. Transcript-speciﬁc decapping and regulated
stability by the human Dcp2 decapping protein. Mol. Cell Biol. 28, 939–948.
Li, Y., Ho, E.S., Gunderson, S.I., Kiledjian, M., 2009. Mutational analysis of a Dcp2-binding
element reveals general enhancement of decapping by 5′-end stem–loop
structures. Nucleic Acids Res. 37, 2227–2237.
Martin, S.A., Moss, B., 1975. Modiﬁcation of RNA by mRNA guanylyltransferase and
182 S. Parrish et al. / Virology 393 (2009) 177–182mRNA (guanine-7-)methyltransferase from vaccinia virions. J. Biol. Chem. 250,
9330–9335.
McLennan, A.G., 2006. The Nudix hydrolase superfamily. Cell Mol. Life Sci. 63,
123–143.
McLennan, A.G., 2007. Decapitation: poxvirus makes RNA lose its head. Trends
Biochem. Sci. 32, 297–299.
Mildvan, A.S., Xia, Z., Azurmendi, H.F., Saraswat, V., Legler, P.M., Massiah, M.A., Gabelli,
S.B., Bianchet, M.A., Kang, L.W., Amzel, L.M., 2005. Structures and mechanisms of
Nudix hydrolases. Arch. Biochem. Biophys. 433, 129–143.
Parrish, S., Moss, B., 2006. Characterization of a vaccinia virus mutant with a deletion of
the D10R gene encoding a putative negative regulator of gene expression. J. Virol.
80, 553–561.
Parrish, S., Moss, B., 2007. Characterization of a second vaccinia virus mRNA-decapping
enzyme conserved in poxviruses. J. Virol. 81, 12973–12978.
Parrish, S., Resch, W., Moss, B., 2007. Vaccinia virus D10 protein has mRNA decapping
activity, providing a mechanism for control of host and viral gene expression. Proc.
Natl. Acad. Sci. U. S. A. 104, 2139–2144.
Piccirillo, C., Khanna, R., Kiledjian, M., 2003. Functional characterization of the
mammalian mRNA decapping enzyme hDcp2. RNA 9, 1138–1147.
Rodriguez, J.M., Salas, M.L., Santaren, J.F., 2001. African swine fever virus-induced
polypeptides in porcine alveolar macrophages and in Vero cells: two-dimensional
gel analysis. Proteomics 1, 1447–1456.
Salas, M.L., Kuznar, J., Vinuela, E., 1981. Polyadenylation, methylation, and cappingof the RNA synthesized in vitro by African swine fever virus. Virology 113,
484–491.
Salas, M.L., Rey-Campos, J., Almendral, J.M., Talavera, A., Vinuela, E., 1986. Transcription
and translation maps of African swine fever virus. Virology 152, 228–240.
Santaren, J.F., Vinuela, E., 1986. African swine fever virus-induced polypeptides in Vero
cells. Virus Res. 5, 391–405.
Shors, T., Keck, J.G., Moss, B., 1999. Down regulation of gene expression by the vaccinia
virus D10 protein. J. Virol. 73, 791–796.
Steiger, M., Carr-Schmid, A., Schwartz, D.C., Kiledjian, M., Parker, R., 2003. Analysis of
recombinant yeast decapping enzyme. RNA 9, 231–238.
Tabares, E., Martinez, J., Ruiz Gonzalvo, F., Sanchez-Botija, C., 1980. Proteins speciﬁed by
African swine fever virus. II. Analysis of proteins in infected cells and antigenic
properties. Arch. Virol. 66, 119–132.
van Dijk, E., Cougot, N., Meyer, S., Babajko, S., Wahle, E., Seraphin, B., 2002. Human
Dcp2: a catalytically active mRNA decapping enzyme located in speciﬁc
cytoplasmic structures. EMBO J. 21, 6915–6924.
Wang, Z., Kiledjian, M., 2001. Functional link between the mammalian exosome and
mRNA decapping. Cell 107, 751–762.
Wang, Z., Jiao, X., Carr-Schmid, A., Kiledjian, M., 2002. The hDcp2 protein is a mammalian
mRNA decapping enzyme. Proc. Natl. Acad. Sci. U. S. A. 99, 12663–12668.
Xu, J., Yang, J.Y., Niu, Q.W., Chua, N.H., 2006. Arabidopsis DCP2, DCP1, and VARICOSE
form a decapping complex required for postembryonic development. Plant Cell 18,
3386–3398.
